DIA449.42+4.74 1.07%
SPX6,466.58+20.82 0.32%
IXIC21,713.14+31.24 0.14%

Gemilang International Full Year 2024 Earnings: US$0.004 loss per share (vs US$0.011 loss in FY 2023)

Simply Wall St·02/20/2025 22:47:49
Listen to the news

Gemilang International (HKG:6163) Full Year 2024 Results

Key Financial Results

  • Revenue: US$23.0m (up 61% from FY 2023).
  • Net loss: US$1.03m (loss narrowed by 63% from FY 2023).
  • US$0.004 loss per share (improved from US$0.011 loss in FY 2023).
earnings-and-revenue-history
SEHK:6163 Earnings and Revenue History February 20th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Gemilang International's share price is broadly unchanged from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 3 warning signs for Gemilang International that you need to be mindful of.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.